Clinical trial Recruiting at 1 site Observational Ages Any age to 10

Monitoring hand, foot and mouth disease in children

Official title: Prospective Clinico-virological Surveillance of Diseases Foot-hand-mouth/Herpangina Associated With Enteroviruses in Pediatric Outpatients

Run by University Hospital, Clermont-Ferrand · NCT06263439 · Data updated 2026-11-12

This study is trying to find out which types of viruses cause hand, foot, and mouth disease in kids by collecting samples from children with symptoms to help track outbreaks.

More Hand-foot-and-mouth Disease trials

Quick facts

Study typeObservational
AgesAny age to 10 Years
SexAll
Enrollment3000 (estimated)
SponsorUniversity Hospital, Clermont-Ferrand
Academic / other
Locations1 site (Clermont-Ferrand)
StatusRecruiting
StartedJune 20, 2023
Main results expectedJune 20, 2028
Study endsJune 20, 2028
Registry record updatedFebruary 16, 2024
Trial IDNCT06263439 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are children aged 0 to 10 years who show signs of hand, foot and mouth disease or herpangina.

Probably not a fit

Patients who refuse to participate or are older than 10 years may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to identify the types of enteroviruses responsible for hand, foot and mouth disease (HFMD) and herpangina in pediatric outpatients. Children aged 0 to 10 years presenting with symptoms suggestive of these conditions will have throat or mouth swabs collected by pediatricians. The samples will be sent to a national reference laboratory for enterovirus detection and genotyping, while demographic and clinical data will also be gathered during the consultation. The study seeks to detect potential epidemics and compare the characteristics of different enterovirus types.

Why it matters

Potential benefit: If successful, this study could enhance early detection and management of enterovirus infections in children.

How similar studies have gone: Other studies have successfully monitored enterovirus infections, making this approach both relevant and potentially impactful.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged 0 to 10 years presenting with HFMD or herpangina

Exclusion Criteria:

* Refusal to participate by holders of parental authority
* Refusal to participate for children over 3 years of age

Where it's running

  • CHU de Clermont-Ferrand
    Clermont-Ferrand, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.